A xeno-free red blood cell differentiation formula models sickle cell disease from somatically sourced patient iPSCs.

Saved in:
Bibliographic Details
Title: A xeno-free red blood cell differentiation formula models sickle cell disease from somatically sourced patient iPSCs.
Authors: Conway AJ; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA., Rosanwo TO; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Williamson TE; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA., Landry S; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA., Kinney MA; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA., Clark MA; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA., Vo LT; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA., Rowe RG; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Marion W; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA., Zhang Y; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA., Mullin NK; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA., Shi M; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA., Archer NM; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Heeney MM; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Schlaeger TM; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA., Bauer DE; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Duraisingh MT; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA., Brugnara C; Department of Laboratory Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA., North TE; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA. Electronic address: Trista.North@childrens.harvard.edu., Daley GQ; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA. Electronic address: George_Daley@childrens.harvard.edu.
Source: Experimental hematology [Exp Hematol] 2025 Dec; Vol. 152, pp. 105264. Date of Electronic Publication: 2025 Sep 14.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Inc Country of Publication: Netherlands NLM ID: 0402313 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2399 (Electronic) Linking ISSN: 0301472X NLM ISO Abbreviation: Exp Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2399
DOI:10.1016/j.exphem.2025.105264